Search
-
News
A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.
… Wednesday, November 22, 2017 Summary Scientists at Memorial Sloan Kettering have developed a mouse model of a rare type of liver cancer. It should aid the search for effective therapies. Some diseases are rare. Others are ultrarare. But if you have an ultrarare condition, that qualifier is little consolation
-
News
Meet Vanessa Tran, a nurse turned volunteer who uses art to support healing.
… Tuesday, December 31, 2019 Vanessa Tran folding paper cranes Inspired by the children’s book Sadako and the Thousand Paper Cranes, Vanessa Tran folded 1,000 origami cranes. Photo: Vanessa Tran Vanessa Tran posing with a locker full of paper cranes The paper cranes are stacked neatly in her MSK locker
-
News
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
… Thursday, October 31, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Deb Schrag and Lorenz Studer Elected to the National Academy of Medicine Deb Schrag and Lorenz Studer Elected to the National Academy of Medicine Deb Schrag, MD, MPH , Chair
-
News
Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.
… Tuesday, July 15, 2014 Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the revered list 25 years ago,
-
News
The atomic structure of an elusive type of membrane protein has finally been solved by scientists at the Sloan Kettering Institute.
… Wednesday, January 17, 2018 Summary Scientists in the Sloan Kettering Institute have solved the structure of an integral membrane protein, a major advance in basic biochemistry that could also lead to new cancer treatments. Every second millions of chemical reactions take place in your cells to kindle
-
News
… Wednesday, November 30, 2022 When Chris Scott met with his urologist in January 2022, he thought they’d talk about an issue he was having with his prostate. But the conversation took a very different turn after Chris, 61, got a CT scan CT scan of his abdomen. On his pancreas was a cyst the size of a
-
News
Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
… Tuesday, October 5, 2021 Pick up any immunology textbook and you’ll find an explanation of the “innate” and “adaptive” arms of the immune system. The innate arm is active from birth and responds to a predefined set of common threats; the adaptive arm takes time to develop but is more versatile at combatting
-
News
The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation.
… Friday, January 8, 2016 Summary Lung cancer causes more deaths in the United States than colon, breast, and prostate cancers combined. The Druckenmiller Center gathers scientists and physicians from across MSK to advance our understanding of the disease, examine novel treatments in preclinical models
-
News
Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes.
… Tuesday, March 2, 2021 Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes (PROs), according to our study published recently in Neurosurgery . (1) Historically, these tumors have been
-
News
Chris Bourne is the first recipient of the MERIT Sawyers Fellowship.
… Thursday, February 10, 2022 Chris Bourne remembers the moment he knew he wanted to become a researcher. He had just completed freshman year at Swarthmore College in Pennsylvania and landed a summer internship with a pharmaceutical company near where he had grown up in South Brunswick, New Jersey. “I’